10 results were returned
Yesterday, the German Bundestag approved the draft law 18/11238 enabling ratification of the “Protocol on Privileges and Immunities of the Unified Patent Court”.
Germany's Federal Cartel Office has taken the unusual step of suggesting that first instance courts hearing ten Nokia v Daimler cases make a reference to the CJEU. Some have speculated that this intervention means that ...
In the wake of the COVID-19 pandemic the German government has recently passed a “corona crisis package”. The so-called Act for protecting the Population in the Event of an Epidemic Situation of National Importance, the ...
The European Patent Office (EPO) and the participating countries are in the final stages of establishing the Unitary Patent and the Unified Patent Court (UPC). This represents the biggest change to patent law in Europe ...
We were successful in defending our clients in a major Supplementary Protection Certificate (SPC) case.
The Federal Supreme Court's Cartel Senate has given its written reasons in the Sisvel v Haier case. In two areas, it seems that Germany has moved closer to the opinion of the Court of Appeal in Unwired Planet. The ...
Almost two years ago, the Higher Regional Court Düsseldorf first iterated new liability criteria with respect to Second Medical Use Patents (cf. decision Östrogenblocker of May 5, 2017, docket no. I-2 W 6/17).
This decision follows the recent trend for the ECJ to give more straightforward interpretations of the SPC Regulation, providing certainty for users of the system.
International law firm Bird & Bird has advised long term client Precision for Medicine, part of the Precision Medicine Group, on its acquisition of Swiss company SimplicityBio from its founders.